These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A new era in the management of pulmonary arterial hypertension related to scleroderma: endothelin receptor antagonism. Hachulla E; Coghlan JG Ann Rheum Dis; 2004 Sep; 63(9):1009-14. PubMed ID: 15308510 [TBL] [Abstract][Full Text] [Related]
3. Clinical features and endothelin receptor antagonist in primary Sjögren's syndrome with pulmonary arterial hypertension. Chen CH; Chen HA; Yang KY; Yu WC; Liao HT; Huang DF Scand J Rheumatol; 2006; 35(3):245-7. PubMed ID: 16766376 [No Abstract] [Full Text] [Related]
4. Bosentan for the treatment of adult pulmonary hypertension. Dwyer N; Kilpatrick D Future Cardiol; 2011 Jan; 7(1):19-37. PubMed ID: 21174507 [TBL] [Abstract][Full Text] [Related]
5. [Endothelin receptor antagonist bosentan. Breakthrough in the treatment of pulmonary hypertension]. MMW Fortschr Med; 2004 Dec; 146(50):72-3. PubMed ID: 15666438 [No Abstract] [Full Text] [Related]
6. [PAH and many other indications. Old and new endothelin receptor antagonists.]. Schmitz J; Holzgrabe U Pharm Unserer Zeit; 2010 Nov; 39(6):430-5. PubMed ID: 20967930 [No Abstract] [Full Text] [Related]
7. Bosentan therapy for pulmonary arterial hypertension. Rubin LJ; Badesch DB; Barst RJ; Galie N; Black CM; Keogh A; Pulido T; Frost A; Roux S; Leconte I; Landzberg M; Simonneau G N Engl J Med; 2002 Mar; 346(12):896-903. PubMed ID: 11907289 [TBL] [Abstract][Full Text] [Related]
8. Successful treatment of persistent pulmonary hypertension of the newborn with bosentan. Nakwan N; Choksuchat D; Saksawad R; Thammachote P; Nakwan N Acta Paediatr; 2009 Oct; 98(10):1683-5. PubMed ID: 19523174 [TBL] [Abstract][Full Text] [Related]